Advancements in Imaging Biomarkers Within the Cancer biomarker Market
Imaging biomarkers are becoming a key segment in the Cancer biomarker Market. Technologies like PET, MRI, and CT scans, when paired with biomarkers, offer enhanced visualization of tumor activity.
These advancements support early detection, precise monitoring, and better treatment planning. As imaging technology evolves, its integration with biomarkers will continue to enhance oncology outcomes.
Market Outlook: The cancer biomarker market, valued at USD 15.9 billion in 2022, is forecasted to reach USD 27.8 billion by 2030, expanding at a 9.8% CAGR.
1 View